(19)
(11) EP 2 004 655 A1

(12)

(43) Date of publication:
24.12.2008 Bulletin 2008/52

(21) Application number: 07734180.8

(22) Date of filing: 26.03.2007
(51) International Patent Classification (IPC): 
C07D 487/06(2006.01)
A61P 35/00(2006.01)
A61K 31/5517(2006.01)
(86) International application number:
PCT/IB2007/000859
(87) International publication number:
WO 2007/113647 (11.10.2007 Gazette 2007/41)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 04.04.2006 US 789351 P

(71) Applicant: Pfizer Products Incorporated
Groton, CT 06340 (US)

(72) Inventors:
  • NINKOVIC, Sacha
    San Diego, CA 92121 (US)
  • RYNBERG, Raymond
    Spring Valley, CA 91978 (US)

(74) Representative: Nevant, Marc 
Pfizer European Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) POLYMORPHIC FORMS OF (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PYRAZOL-4 L)-1-OXO-2,6-DIHYDRO-1H-Ý1,2¨DIAZEPINOÝ4,5,6-CD¨INDOL-8-YL)ACETAMIDE